Table 1 Relationship between the circZFR expression and clinical parameters of cervical cancer patients
Variable | Case No | Mean ± SD | P value | |
|---|---|---|---|---|
Age (years) | ≤50 | 20 | 4.14±2.75 | 0.535 |
> 50 | 20 | 4.86±4.34 | ||
Tumor stage | ≤IB2+IIA1 | 32 | 3.50±2.37 | 0.389 |
>IB2 | 8 | 4.75±3.84 | ||
Grade | G2 | 16 | 4.24±4.11 | 0.463 |
G3 | 13 | 5.33±3.68 | ||
Invasion depth | < 2/3 | 27 | 3.91±2.98 | 0.481 |
≥2/3 | 13 | 4.78±3.89 | ||
Lymphatic metastasis | Negative | 33 | 4.34±2.94 | 0.049 |
Positive | 4 | 8.11±7.02 | ||
Vascular Invasion | Negative | 30 | 4.70±3.72 | 0.856 |
Positive | 7 | 4.98±3.49 | ||
SCC Ag (ng/mL) | < 1.5 | 19 | 3.44±2.53 | 0.049 |
≥1.5 | 21 | 5.67±4.28 | ||
Ki67 | < 80% | 14 | 2.89±2.48 | 0.003 |
≥80% | 13 | 6.22±2.83 | ||